Document is current
Any future updates will be listed below
-
Authors
Shim, Ji-Su
Kim, Min-Hye
Kang, Sung-Yoon
Lee, Ji-Ho
Jo, Eun-Jung
Lee, Byung-Jae
Cho, Sang-Heon
Jang, JeeEun
Song, Woo-Jung
-
Funding
Funding for this research was provided by:
This study was funded by MSD Korea Ltd., Seoul, Republic of Korea.
- License Information
-
More Information
Article History
Received: 9 March 2026
Accepted: 24 April 2026
First Online: 8 May 2026
Declarations
:
: WJS declares grants from MSD, Daewoong Pharmaceutical, and AstraZeneca, consulting fees from Merck, Bellus, AstraZeneca, Shionogi, and GSK, and lecture fees from Thermo Fischer/Immunotek, Celltrion, Merck, AstraZeneca, GSK, Sanofi, and Novartis. Other authors have no potential conflicts of interest to disclose.
: The study was approved by the Institutional Review Board (IRB No. 2021-07-046) for each participating hospital and written informed consent forparticipation was obtained from all study subjects.
